merger

Showing 10 posts of 70 posts found.

AstraZeneca image

AstraZeneca ‘rejects Pfizer bid’

April 22, 2014
Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger

AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …

Forest image

Forest sold to Actavis for $25 billion

February 18, 2014
Sales and Marketing Actavis, CNS, Forest, acquisition, labs, merger, synergy

The rumours of a substantial deal for Forest have been proven true after Actavis announced this afternoon that it will …

GE image

GE makes $1 billion Thermo deal

January 7, 2014
Sales and Marketing general electric, merger, thermo fisher

General Electric Company is to pay around $1.06 billion in a bid to boost its life sciences capability in pharma’s …

Roche image

Roche rules out merger talk

October 18, 2013
Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger

Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …

Analysts want AstraZeneca-AbbVie tie-up

June 20, 2012
Sales and Marketing AbbVie, Abbott, AstraZeneca, merger

Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …

OSI Pharmaceuticals

OSI resists Astellas and invites other offers

March 16, 2010
Sales and Marketing Astellas, OSI, merger

A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …

Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

2-in-1: Merck and Schering-Plough

April 8, 2009
Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …

The Pfizer-Wyeth merger

February 2, 2009
Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales

Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …

Escape routes diminishing for Aventis

February 12, 2004
Sanofi-Aventis, acqisition, merger

 Aventis’ chances of sidestepping the hostile takeover bid from Sanofi-Synthelabo are looking increasingly less likely as the ‘alternative scenarios’ it …

The Gateway to Local Adoption Series

Latest content